Skip to main content
. 2022 Mar 22;12:726985. doi: 10.3389/fonc.2022.726985

Figure 2.

Figure 2

The new CAR-NK-92 (SP) cell line could be stably passaged and expanded independently of exogenous IL-2. (A) Short term proliferation of SP and NK92 cells exposed to 10 U/mL IL-2(left) and 100 U/mL IL-2 (right) supplements. (B) 5-Ethynyl-2’-deoxyuridine (EdU) assay and (C) cell cycle analysis were performed using SP cells and NK92 cells cultured with the 100 U/mL IL-2 supplement. (D) Shown is the percentage of apoptotic cells was detected by FCM after culturing NK92 and SP cells in PBS for 8 hours. The left sides of panels (B–D) show a representative sample image of the experimental results, and the right side shows the statistical results of three parallel experiments expressed as mean ± SEM (n = 3, **P < 0.01, ***P < 0.001).